Modeling Down Syndrome neurodevelopment with isogenic cerebral organoids
Source Czerminski et al., 2022 · University of Massachusetts Medical School · 10.1101/2022.05.25.493459;
Abstract
This protocol generates isogenic trisomic and disomic cerebral organoids from Down syndrome patient-derived iPSCs to model early fetal brain development. The organoids are characterized through transcriptomics and media analysis to identify neurodevelopmental and neurodegenerative phenotypes associated with trisomy 21, including increased amyloid-beta secretion and subtle transcriptional changes in key developmental genes.
Protocol overview
30 steps across 8 phases
- 1 Culture iPSCs on vitronectin-coated plates
- 2 Passage iPSCs every 3-4 days
- 3 Verify chromosome 21 status by FISH
- 1 Prepare embryoid bodies (EBs)
- 2 Transfer aggregates to Matrigel embedding (Day 7)
- 3 Initiate orbital shaker culture (Day 14)
- 4 Maintain organoid culture through day 90
- 1 Collect media for amyloid-beta analysis
- 2 Harvest organoids for RNA extraction
- 3 Homogenize organoids
- 1 Extract RNA from Trizol homogenate
- 2 Treat with DNase I
- 3 Purify RNA with RNeasy MinElute columns
- 4 Assess RNA quality
- 5 Prepare strand-specific cDNA libraries
- 1 Sequence on Illumina platform
- 1 Align reads to reference genome
- 2 Count reads to genes
- 3 Normalize and identify differentially expressed genes
- 4 Perform cell type deconvolution
- 5 Generate publication-quality graphs
- 1 Prepare media samples for ELISA
- 2 Perform ultrasensitive amyloid-beta ELISA
- 3 Read absorbance
- 4 Generate standard curve and calculate concentrations
- 5 Normalize to RNA content
- 1 Perform reverse transcription
- 2 Set up qPCR reactions
- 3 Perform qPCR on thermal cycler
- 4 Analyze qPCR data
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in Czerminski et al., 2022. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol